BRIEF-Greenwich Lifesciences Inc - Initiates New Us Clinical Sites For Flamingo-01 Phase Iii Trial

Greenwich LifeSciences, Inc.

Greenwich LifeSciences, Inc.

GLSI

0.00

March 19 (Reuters) - Greenwich Lifesciences Inc GLSI.O:

  • GREENWICH LIFESCIENCES INC - INITIATES NEW US CLINICAL SITES FOR FLAMINGO-01 PHASE III TRIAL

  • GREENWICH LIFESCIENCES INC - FLAMINGO-01 PHASE III TRIAL ACTIVATED AT CITY OF HOPE NETWORK SITES

  • GREENWICH LIFESCIENCES INC - FLAMINGO-01 TRIAL SITES COULD INCREASE TO 190-200 FROM CURRENT 160

Source text: ID:nGNX766qnf

Further company coverage: GLSI.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.